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ABSTRACT
Objectives: To investigate the role of primary care in the
management of HIV and estimate primary care-associated
costs at a time of rising prevalence.
Methods: Retrospective cohort study between 1995 and
2005, using data from general practices contributing data
to the UK General Practice Research Database. Patterns
of consultation and morbidity and associated consultation
costs were analysed among all practice-registered
patients for whom HIV-positive status was recorded in the
general practice record.
Results: 348 practices yielded 5504 person-years (py) of
follow-up for known HIV-positive patients, who consult in
general practice frequently (4.2 consultations/py by men,
5.2 consultations/py by women, in 2005) for a range of
conditions. Consultation rates declined in the late 1990s
from 5.0 and 7.3 consultations/py in 1995 in men and
women, respectively, converging to rates similar to the
wider population. Costs of consultation (general practitioner
and nurse, combined) reflect these changes, at £100.27 for
male patients and £117.08 for female patients in 2005.
Approximately one in six medications prescribed in primary
care for HIV-positive individuals has the potential for major
interaction with antiretroviral medications.
Conclusion: HIV-positive individuals known in general
practice now consult on a similar scale to the wider
population. Further research should be undertaken to
explore how primary care can best contribute to
improving the health outcomes of this group with chronic
illness. Their substantial use of primary care suggests
there may be potential to develop effective integrated
care pathways.
The prevalence of HIV in the UK has increased
since the introduction of highly active antiretro-
viral therapy (HAART) in the mid 1990s, which
improved the survival of HIV-positive individuals.
It also reflects changing patterns of international
migration. An estimated 77 400 individuals were
living with HIV by 2007.1
UK residents are eligible to ‘‘register’’ free of
charge with a general practitioner (GP) or primary
care practice, which provides most routine care and
can refer for specialist consultation. HIV-related
medical care is unusual within the UK in being
delivered largely by specialist services, in which
many HIV-positive individuals have also obtained
some of the care usually provided by a GP.2
Improved survival and increasing prevalence pre-
sents challenges for these traditional models of
HIV care, as the scope of care required and the
number of patients both expand. This is likely to
continue with the increasing move to normalise
HIV testing.3 Although antiretroviral drugs are still
prescribed only by specialist services, with very rare
exceptions, the transformation of HIV into a
chronic disease presents new challenges for the
UK health services (NHS) in preventive and long-
term care, which is generally the domain of
primary care.4 Wider changes in NHS commission-
ing and delivery, such as the establishment of
Quality and Outcomes Framework payments
rewarding the management of chronic disease,5
have highlighted the need to develop and evaluate
more holistic models of care for a surviving and
ageing cohort of HIV-positive individuals, whose
medical needs and mortality rates closely approx-
imate those of the general population.4 6
Little is known about existing patterns of care
for HIV-positive individuals in UK primary care. At
least half,7 and possibly up to 78% of people living
with HIV have disclosed their status to a GP.8
There is anecdotal evidence that many seek regular
primary care services especially if HIV specialist
care is only available outside of their district of
residence (G Rooney, personal communication,
2008). However, the extent, characteristics and
cost of HIV management in UK primary care
remain largely unknown. Information on current
management and costs in primary care is needed to
inform the rational development of HIV services in
recognition that HIV is now a chronic disease,9 and
to build on current practice in maximising the
quality of care.
In this study, which draws on data from
unselected HIV-positive individuals known to their
GP, we describe patterns of consultation and
morbidity in primary care and associated costs,
with a view to informing the development of
integrated care.
METHODS
Population and sampling
The population studied was derived from the
General Practice Research Database (GPRD),
described elsewhere.7 10 Briefly, the GPRD is a
database of computerised clinical records in primary
care, containing anonymised data on 4.7% (2.8
million in 2005) of the UK population. It is broadly
demographically representative, and has been widely
used and validated in pharmacoepidemiological,
epidemiological and public health research.10
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The data include descriptions of symptoms, investigations
and diagnoses, as Read or OXMIS (Oxford Medical Information
Systems) codes, with data on prescriptions, consultations, age
and gender and region, at the level of the strategic health
authority.
We studied all individuals recorded as HIV positive and
registered in a GPRD practice at any time from 1995 to 2005
inclusive. A patient started contributing to the study on the
latest of three possible dates: the date when an HIV-positive
code was first recorded; the date when the patient first
registered with the practice; or when the practice provided up-
to-standard data. A patient stopped contributing either on being
recorded as ‘‘transferring out’’ of the practice (when a patient
moves out of the practice or dies) or on the practice’s last
collection date, whichever was earlier.
Practices could contribute data to the GPRD only when they
met data quality requirements and data recorded before this
were discarded. A total of 389 practices contributed to the
GPRD between 1995 and 2005. When a practice stopped
contributing it was not replaced, but practices could join at
any time.
Consultation rates and economic costing
We measured the annual rate of face-to-face, telephone and
home visits with GPs and practice nurses from 1995 to 2005, as
recorded in the GPRD, using person-years as the denominator.
We estimated personnel costs of consultation using published
unit costs11 to cost GP and nurse consultations. The cost year
for the analysis was 2005–6. The number of consultations was
restricted to one GP and one nurse consultation per day per
patient to minimise the inadvertent duplication of consulta-
tions as a result of, for example, entering administrative data.
The type of consultation, which is selected by the member of
staff entering the records, was classified as face-to-face,
telephone and out of hours/home visits (combined), and costed
accordingly. The data available did not allow reliable estimation
of the costs of prescriptions, tests or referrals.
In order to compare consultation patterns among HIV-
positive individuals with the wider population we needed to
compare these with consultation patterns among individuals of
comparable age and gender. We therefore directly age-standar-
dised our study population to published estimates of consulta-
tion rates,12 estimated from the QResearch database. This is also
based on a widely used general practice software system. We
could not compare with consultation rates in the general
population using the GPRD because our data licence was
restricted to our study population and no published estimates
are available. Similarly, we cannot compare consultation
patterns for specific morbidities with the wider population.
Comparison with consultation rates in specialist HIV services
was not possible because these data record only in aggregate the
proportion of quarter years in which at least one attendance
occurs, and the number of attendances per patient cannot be
inferred.
Estimated medication costs of specific antiretroviral therapies
published at the end of the 2005–6 financial year were also
identified in order to compare the magnitude of primary care
consultation costs and HAART costs.13
HIV morbidity and clinical care
Consultation rates were calculated for the following preselected
general categories of common and/or HIV-related morbidities
among prevalent HIV cases: upper respiratory infections, lower
respiratory infections, tuberculosis, sore throat, skin infections
and other skin conditions, non-Hodgkin’s lymphoma, fungal
infections, herpes zoster, headache, gastrointestinal symptoms,
gastrointestinal infections and mental health-related problems.
These were selected by the authors as common problems
presenting in HIV-positive individuals, based on the experience
of specialist centres, but which need not necessarily indicate a
need for specialist care.
Finally, classes of drugs considered by HIV specialists to
present a high potential for adverse interactions with commonly
used HIV antiretroviral medications were identified, through a
workshop held at a specialist HIV care centre, at which the
opinions of clinicians expert in the care of HIV were consulted
by the clinical authors of the paper and consensus was reached.
Ethical approval was given by the Independent Scientific
Advisory Committee of GPRD under delegated authority.
Analysis
We estimated the following:
c GP and nurse consultation rates among HIV patients known
to primary care by gender and HIV morbidity, compared
with consultation rates for the GP-registered population;
c The cost of GP and nurse consultations per patient by year
and by gender;
c Consultation rates for selected morbidities;
c The proportion of all prescriptions in 2005 that included a
medication considered to present a high potential for
adverse interaction with HIV medications.
A detailed analysis of consultation patterns was performed
for 2005, in which patients were categorised by gender, level of
deprivation, age and area of residence, and the rates for these
different categories were estimated. Four categories were used
to ascribe area of residence: London; urban (area outside of
London); intermediate and rural. Level of deprivation was
classified into lower, middle and upper quartiles. Possible factors
associated with a rise/fall in consultation rates were investi-
gated. Variables were considered in a multivariable analysis if
they were shown to be significant (p,0.05) in the univariable
analysis. All first-level interactions were investigated by adding
them to the multivariable model consecutively. Interactions
between covariates that were non-ignorable were defined as
having hazard ratios that were less than 0.7 or greater than 1.3
and the global p value was p,0.05. Non-ignorable interactions
identified were dealt with through stratification.
Poisson regression was used to calculate incidence rate ratios
for consultations. The standard errors for the incidence rate
ratios were adjusted to take account of within-patient cluster-
ing of consultations. All analyses were performed using STATA
(version 9.0).
RESULTS
Population available for analysis
Data were available for a total of 1438 men and 751 women
recorded as HIV positive, derived from 348 practices.
Supplemental table 1 (available online only) describes the
demographic profile of these individuals and supplemental table
2 (available online only) summarises the size of the individual
study populations available for each year 1995–2005. The
median duration of contribution by practices was 11 years
(interquartile range (IQR) 7, 11 years; range 5 months to
11 years to the nearest month). The median follow-up time
for all men and women in the GPRD is 5 years (IQR 2 years and
Health services research
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9 weeks to 8 years 24 weeks) and 5 years and 16 months (IQR
2 years and 42 weeks to 9 years), respectively.
Consultation rates among HIV-positive patients
Total consultation rates (GP, nurse, face-to-face and by phone)
in 1995 were 5.0/person-year (py) for men and 7.3/py for
women, and face-to-face GP consultations were 4.0/py and 6.0/
py, respectively. These had dropped by 2005 to 4.2/py, 5.2/py,
3.1/py and 3.5/py, respectively. Figure 1 shows face-to-face
consultation rates among HIV-positive individuals in the GPRD,
in comparison with the wider practice population. Whereas
crude consultation rates declined gradually, standardisation to
the registered general practice population reveals a more marked
drop in face-to-face consultation rates after the widespread
introduction of HAART around 1996, which was not paralleled
in the population as a whole. Figure 2 describes consultation
patterns among HIV-positive individuals by consultation type.
Nurse consultations followed a steady upward trend through-
out the period of study in line with national trends.12
Table 1 reports a multivariable analysis of consultation rates
by gender, age and deprivation level for 2005, the most recent
year studied. These analyses were stratified by area of residence
because of significant interactions with the demographic
variables studied. Overall, primary care consultation rates
increased with increasing rurality. Consultation rates were also
higher among women compared with men in urban areas, with
the largest gender difference observed for individuals living in
London: adjusted incidence rate ratio 1.45 (95% CI 1.11 to 1.91).
There were no significant associations with age, except among
individuals living in urban areas outside of London, where
consultation rates increased with age. Level of deprivation was
not associated in any of the three area types considered.
Cost of primary care consultation among HIV patients
Details of an economic analysis of consultation costs are
presented in supplemental table 2 (available online only). A
decline in the total costs of consultations (GP and nurse
combined) was seen for female patients from £211.59 in 1995 to
£117.08 in 2005. In male patients, the total costs of consulta-
tions (GP and nurse combined) decreased from £147.26 in 1995
to £86.29 in 2001, whereas they increased to £100.27 in 2005.
The total cost of GP consultations was substantially higher than
the total cost of practice nurse consultations, as a result of a
higher GP consultation rate and a higher GP unit cost.
Consultation rates by morbidity
Figure 3 shows consultation rates among HIV-positive indivi-
duals for selected morbidities over the period 1995–2005.
Consultation occurs most commonly for respiratory infections,
with an average rate of 240.1 (95% CI 184.4 to 312.8) per
1000 py for upper respiratory infections and 253.2 (95% CI
195.8 to 327.6) for lower respiratory infections. Consultation
rates for respiratory infections, sore throat and skin disease
dropped between 1995 and 1998, with the biggest drop in upper
respiratory infections at 240.1 (95% CI 184.4 to 312.8) in 1995
to 115.7 (95% CI 101.0 to 132.4) in 1998 and skin disease at
135.3 (95% CI 95.2 to 192.4) to 47.4 (95% CI 38.3 to 58.5).
In this sample, 37.3% of men and 27.0% of women
contributing data during 2005 had been recorded at some time
Figure 1 Primary care face-to-face consultation rates among HIV-positive individuals (N = 2189)* by comparison with the general primary care
registered population.{ *See supplemental table 1 (available online only) for annual denominators. {Consultation rates among HIV-positive individuals
taken from the General Practice Research Database were directly age standardised to published rates calculated from the general practice population
using the QResearch database and reference number 12, using 5-year age categories.
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as having either symptoms or a diagnosis of mental health
problems since their first recorded HIV-positive record.
Prescriptions
The proportion of prescriptions to HIV-positive individuals that
were considered to have a major potential to interact with HIV
medication was 17.4% (95% CI 16.8% to 18.1%) in 2005, with
no significant change between 1995 and 2005. Benzodiazepines
were the most frequently prescribed drug type,contributing
21.6% of all potential HIV medication-interacting prescriptions,
followed by anti-inflammatory (18.2%), antacid (13.7%), anti-
depressant (13.2%), diuretic (9.2%) and lipid-lowering agents
(8.6%). (Note that many of these may have been initiated in
specialist care and then continued by the GP).
DISCUSSION
Primary care consultation is frequent among HIV-positive
individuals known to the GP, but declined in the mid-1990s,
following the introduction of HAART, reaching similar rates to
the general population. This decline may reflect decreasing
morbidity as a result of antiretroviral therapy. Consultation
frequency remains higher outside London and among older
adults, the latter reflecting wider trends to increased consulta-
tion above the age of 45 years.12 HIV-positive individuals, who
are known to their GPs, consult frequently in primary care for a
wide range of problems, including respiratory, gastrointestinal
and dermatology conditions. A third of patients have had a
mental health-related consultation since their first HIV
diagnosis record.
Our study provides for the first time a description of primary
healthcare provision to patients recorded as HIV positive in the
UK setting, building on previous studies that looked at selected
groups14 and the recently diagnosed.15 The marked drop seen in GP
consultation rates, following the widespread introduction of
HAART, was not seen in the wider population, but a subsequent
steady state in GP consultations, alongside a substantial rise in
nurse consultations, reflects trends in the wider population. As in
the USA, women consult in primary care more frequently than
men.16 Our data confirm both high rates of mental health-related
consultations reported in HIV-positive individuals,17 18 and
demonstrate that primary care staff are aware of these conditions.
Mental health problems are known to be associated with poor
adherence to HAART.19 20 This is also of public health relevance
because HIV-positive men with depression are more likely to
engage in unprotected anal intercourse.21
A major strength of this study is the use of the primary care
records, created in real time, of a large cohort of unselected HIV-
positive individuals. However, there are a number of limita-
tions. We do not know whether all patients with HIV known to
their GP were captured, and we did not have access to the free
text in the GPRD, which may provide additional information.
Some HIV diagnoses may be euphemistically coded, recorded in
free text or not recorded at all, in order to avoid disclosure to
mortgage and life assurance agencies, or to receptionists and
non-clinical practice staff. The date of first diagnosis (as
opposed to the first date of a record appearing in the notes)
may not be accurate unless the GP specifically recorded this by
recording an ‘‘event date’’ different from the date of the record.
It would have been helpful to compare primary care
consultations with HIV specialist consultations, but currently
available data did not allow a meaningful comparison. This
means that we cannot test an alternative hypothesis that the
Figure 2 Primary care consultations among HIV-positive individuals with a general practitioner (GP) or nurse by consultation type (N = 10 292
consultations recorded for 2189 patients). The start date is the first date of recording any HIV-positive medical code. Consultations were restricted to
one nurse and one GP consultation per day to avoid duplication. ‘‘All consultations’’ was defined as all face-to-face, phone and home visit/out-of-hours
consultations combined.
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frequent follow-up usual in monitoring HAART may account
for the reduction in primary care consultations, because HIV
patients’ primary care needs may be largely met during these
specialist follow-up visits.
Consultation behaviour may vary in relation to many factors.
In particular, we are unable to explore the relation of
sociodemographic factors, such as ethnicity, to consultation
patterns among HIV-positive individuals or the wider popula-
tion.
Our cost analysis focused on consultations only, excluding
the cost of drugs, referrals and procedures. Costing of all items
and comparison across time of these complex records, and
comparison of detailed clinical data with the wider population,
was not feasible within the resource constraints of this study.
However, the cost of a typical HAART regimen in 2005
(abacavir, lamivudine and efavirenz) was £8208,13 dwarfing
the consultation costs and any likely primary care prescribing
costs, because antiretroviral drugs are not prescribed in primary
care in the UK. The impact of the patients who have not
disclosed to their GP on costs is hard to ascertain, as it is unclear
whether they will use primary care more or less than those who
have disclosed.
The frequent use of primary care we saw in HIV-positive
individuals lends support to the view that GPs could play a
major role in the maintenance of health in this population.4 Our
data also suggest that interventions to improve care in chronic
illness demonstrated in recent years across a wide range of
conditions4 are likely to be applicable here because a high
proportion of HIV-positive individuals do use primary care
extensively. However, the extent of non-registration with
general practice is not known, and could have an impact on
the potential of such interventions.
Trials of shared care between GPs and specialists, which
notably failed to recruit in the UK before the era of HAART,22
Table 1 Demographic factors associated with primary care consultation rates (per person-year) among HIV-positive individuals by area of residence
in the UK in 2005
Demographic factors No of consultations
Consultation rate/
py
Crude IRR
(95% CI)
Adjusted IRR
(95% CI)
London (n = 565 individuals)
All 1656 3.73 – –
Gender p = 0.002 p = 0.007
Male 972 3.23 1 1
Female 684 4.79 1.48 (1.15 to 1.90) 1.45 (1.11 to 1.91)
Age, grouped, years p = 0.060 p = 0.317
16–24 58 6.45 1.62 (1.04 to 2.54) 1.39 (0.90 to 2.17)
25–34 288 3.98 1 1
35–44 785 3.64 0.92 (0.68 to 1.24) 0.93 (0.69 to 1.26)
45+ 525 3.57 0.90 (0.63 to 1.28) 0.97 (0.67 to 1.40)
Deprivation level p = 0.519
Lower quartile (least deprived) 6 1.33 1
Middle quartiles 1063 3.86 2.58 (0.41 to 16.01)
Upper quartile (most deprived) 587 3.57 2.38 (0.38 to 14.92)
Urban areas outside London (n = 774 individuals)
All 2899 4.52 – –
Gender p = 0.039 p = 0.003
Male 1729 4.22 1 1
Female 1170 5.04 1.19 (1.01 to 1.41) 1.30 (1.09 to 1.54)
Age, grouped, years p = 0.004 p,0.001
16–24 93 3.26 0.74 (0.49 to 1.22) 0.71 (0.47 to 1.08)
25–34 722 4.39 1 1
35–44 1020 3.99 0.91 (0.74 to 1.12) 0.96 (0.78 to 1.18)
45+ 1064 5.51 1.26 (1.03 to 1.53) 1.37 (1.12 to 1.67)
Deprivation level p = 0.178
Lower quartile (least deprived) 373 4.7 1
Middle quartiles 1476 4.19 0.89 (0.69 to 1.15)
Upper quartile (most deprived) 1050 4.98 1.06 (0.82 to 1.38)
Rural-intermediate areas outside London (n = 94 individuals)
All 588 5.65 – –
Gender p = 0.915 –
Male 402 5.61 1 –
Female 186 5.73 1.02 (0.67 to 1.55) –
Age, grouped, years p = 0.403 –
16–34* 96 4.41 1 –
35–44 193 5.53 1.25 (0.73 to 2.16) –
45+ 299 6.29 1.43 (0.85 to 2.38) –
Deprivation level p = 0.447 –
Lower quartile (least deprived) 167 4.88 1 –
Middle quartiles 303 5.76 1.18 (0.73 to 1.91) –
Upper quartile (most deprived) 118 6.82 1.40 (0.83 to 2.35) –
*Age groups 16–24 and 25–34 were collapsed into one category due to small numbers. This category corresponds to five consultations among two individuals aged 16–24 years
and 91 consultations among 21 individuals aged 25–34 years. IRR, incidence rate ratio; py, person-year.
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need to be revisited in the context of HIV as a chronic disease,
with an associated shift in emphasis towards early diagnosis and
health promotion. While communication with the GP is
recommended23 in guidelines for HIV specialists, it is not yet
normalised. However, findings from observational studies
suggest that when the HIV viral load is well controlled, the
frequency of specialist monitoring can be reduced without
compromising the clinical outcome.24 HIV management, seen as
the optimal management of the overall health of HIV-positive
individuals, has the potential to be improved through the
development of a better interface between primary and
secondary care. At present, a high proportion of prescriptions
issued to known HIV-positive individuals are of medications
with potential for interaction with HIV medications. These
may well be unproblematical in this group whose GPs are aware
of their HIV diagnosis—and may have been initiated in the
specialist setting. If paralleled in the half of all HIV-positive
individuals who do not have their HIV diagnosis recorded, and
whose GP may not be aware of it,7 there is potential for
avoidable adverse drug interactions. This finding, in the context
of rapidly evolving and complex HIV medication regimes,
emphasises the need to develop more effective communication
between GPs, patients and HIV specialists in order to minimise
the risks of inadvertent drug prescribing and unnecessary
investigation. Even in the pre-HAART era, registration with
GPs was surprisingly high among HIV-positive individuals,25 but
the role of the GP at that time was to support the patient
through the process of declining health and death. The role of
the GP in HIV is very different now because holistic, preventive
care for patients, and often their families, involves supporting
and managing wider health problems. The provision of smoking
cessation advice, blood pressure, lipid control and contraception
need to be addressed if HIV-positive individuals are to maximise
the opportunities to improve quality of life and increase lifespan
afforded by HAART.
Our earlier study7 showed higher rates of disclosure to
primary care outside London than in the capital. The data
presented here show that HIV-positive individuals also use
primary care more outside London, suggesting that models of
care appropriate to HIV as a chronic illness may be emerging
more rapidly, perhaps through necessity, outside the more
concentrated HIV epidemic and extensive HIV services of
London. It is important to explore how primary care can
improve health outcomes in this group, as their primary care use
suggests that integrated care could be provided.
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Figure 3 Consultation rates for common
morbidities* among individuals
(N = 2189){ recorded in general
practice as HIV-positive patients, 1995–
2005. *Consultations include those
classified as face-to-face, phone, home
visits and out-of-hours consultations and
undertaken by a nurse or general
practitioner for both male and female
patients combined. Morbidities with
consultation rates that were all lower than
0.006 for all years (non-Hodgkin’s
lymphoma, visual disturbance, fungal
infections, tuberculosis and other
gastrointestinal symptoms) are not
displayed here. {See supplemental table 1
(available online only) for annual
denominators.
Key messages
c HIV is now a chronic disease, but little is known about the
contribution of primary care to the management of HIV-
positive individuals.
c Our analysis of primary care data shows that HIV-positive
individuals known to their GP consult primary care at a similar
rate to the general population.
c There is considerable potential for HAART interactions with
primary care prescriptions.
c Research is needed to explore how specialists and primary
care can best interact to improve the health of HIV-positive
individuals.
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